Literature DB >> 12639989

The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis.

Shaosong Zhang1, Carla Weinheimer, Michael Courtois, Attila Kovacs, Cindy E Zhang, Alec M Cheng, Yibin Wang, Anthony J Muslin.   

Abstract

Cardiac hypertrophy is a common response to pressure overload and is associated with increased mortality. Mechanical stress in the heart can result in the integrin-mediated activation of focal adhesion kinase and the subsequent recruitment of the Grb2 adapter molecule. Grb2, in turn, can activate MAPK cascades via an interaction with the Ras guanine nucleotide exchange factor SOS and with other signaling intermediates. We analyzed the role of the Grb2 adapter protein and p38 MAPK in cardiac hypertrophy. Mice with haploinsufficiency of the Grb2 gene (Grb2(+/-) mice) appear normal at birth but have defective T cell signaling. In response to pressure overload, cardiac p38 MAPK and JNK activation was inhibited and cardiac hypertrophy and fibrosis was blocked in Grb2(+/-) mice. Next, transgenic mice with cardiac-specific expression of dominant negative forms of p38alpha (DN-p38alpha) and p38beta (DN-p38beta) MAPK were examined. DN-p38alpha and DN-p38beta mice developed cardiac hypertrophy but were resistant to cardiac fibrosis in response to pressure overload. These results establish that Grb2 action is essential for cardiac hypertrophy and fibrosis in response to pressure overload, and that different signaling pathways downstream of Grb2 regulate fibrosis, fetal gene induction, and cardiomyocyte growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639989      PMCID: PMC153766          DOI: 10.1172/JCI16290

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  14-3-3 proteins block apoptosis and differentially regulate MAPK cascades.

Authors:  H Xing; S Zhang; C Weinheimer; A Kovacs; A J Muslin
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  Prognostic implications of left ventricular hypertrophy.

Authors:  B A Vakili; P M Okin; R B Devereux
Journal:  Am Heart J       Date:  2001-03       Impact factor: 4.749

3.  Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload.

Authors:  G Esposito; S V Prasad; A Rapacciuolo; L Mao; W J Koch; H A Rockman
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

4.  The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy.

Authors:  P Liao; D Georgakopoulos; A Kovacs; M Zheng; D Lerner; H Pu; J Saffitz; K Chien; R P Xiao; D A Kass; Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

5.  Disruption of T cell signaling networks and development by Grb2 haploid insufficiency.

Authors:  Q Gong; A M Cheng; A M Akk; J Alberola-Ila; G Gong; T Pawson; A C Chan
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

6.  Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.

Authors:  T L Yue; J L Gu; C Wang; A D Reith; J C Lee; R C Mirabile; R Kreutz; Y Wang; B Maleeff; A A Parsons; E H Ohlstein
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

Review 7.  Arterial hypertension and cardiac arrhythmias.

Authors:  M G Hennersdorf; B E Strauer
Journal:  J Hypertens       Date:  2001-02       Impact factor: 4.844

8.  Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway.

Authors:  C G Pham; A E Harpf; R S Keller; H T Vu; S Y Shai; J C Loftus; R S Ross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

9.  RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload.

Authors:  J H Rogers; P Tamirisa; A Kovacs; C Weinheimer; M Courtois; K J Blumer; D P Kelly; A J Muslin
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

10.  RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice.

Authors:  J H Rogers; A Tsirka; A Kovacs; K J Blumer; G W Dorn; A J Muslin
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

View more
  70 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  The sarcomeric Z-disc: a nodal point in signalling and disease.

Authors:  Derk Frank; Christian Kuhn; Hugo A Katus; Norbert Frey
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

3.  Role of p38 mitogen-activated protein kinase in cardiac remodelling.

Authors:  S Frantz; T Behr; K Hu; D Fraccarollo; J Strotmann; E Goldberg; G Ertl; C E Angermann; J Bauersachs
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 4.  The role of Neuregulin-1beta/ErbB signaling in the heart.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2008-09-03       Impact factor: 3.905

Review 5.  The Peroxisome Proliferator-Activated Receptor-Gamma Coactivator-1α-Heme Oxygenase 1 Axis, a Powerful Antioxidative Pathway with Potential to Attenuate Diabetic Cardiomyopathy.

Authors:  Maayan Waldman; Michael Arad; Nader G Abraham; Edith Hochhauser
Journal:  Antioxid Redox Signal       Date:  2020-03-25       Impact factor: 8.401

6.  p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.

Authors:  Kazuhiko Nishida; Osamu Yamaguchi; Shinichi Hirotani; Shungo Hikoso; Yoshiharu Higuchi; Tetsuya Watanabe; Toshihiro Takeda; Soh Osuka; Takashi Morita; Gen Kondoh; Yoshihiro Uno; Kazunori Kashiwase; Masayuki Taniike; Atsuko Nakai; Yasushi Matsumura; Jun-ichi Miyazaki; Tatsuhiko Sudo; Kenichi Hongo; Yoichiro Kusakari; Satoshi Kurihara; Kenneth R Chien; Junji Takeda; Masatsugu Hori; Kinya Otsu
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  Distinct cellular and molecular mechanisms underlie functional remodeling of repolarizing K+ currents with left ventricular hypertrophy.

Authors:  Céline Marionneau; Sylvain Brunet; Thomas P Flagg; Thomas K Pilgram; Sophie Demolombe; Jeanne M Nerbonne
Journal:  Circ Res       Date:  2008-05-01       Impact factor: 17.367

8.  A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.

Authors:  Irene Pérez López; Luca Cariolato; Darko Maric; Ludovic Gillet; Hugues Abriel; Dario Diviani
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

9.  A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.

Authors:  Raghu S Nagalingam; Nagalingam R Sundaresan; Mahesh P Gupta; David L Geenen; R John Solaro; Madhu Gupta
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

10.  Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways.

Authors:  Suraiya Rasheed; Jasper S Yan; Adil Hussain; Bruce Lai
Journal:  J Transl Med       Date:  2009-08-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.